Dr. Daniel Almquist
Claim this profileSanford USD Medical Center - Sioux Falls
Expert in Cancer
Expert in Breast Cancer
84 reported clinical trials
141 drugs studied
Area of expertise
1Cancer
Global LeaderStage IV
p16 positive
Stage III
2Breast Cancer
Global LeaderHER2 positive
ER positive
HER2 negative
Affiliated Hospitals
Clinical Trials Daniel Almquist is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Trastuzumab Emtansine
for Salivary Gland Cancer
This phase II trial tests whether ado-trastuzumab emtansine works to shrink tumors in patients with HER2-positive salivary gland cancer that has come back (recurrent), spread to other places in the body (metastatic), or cannot be removed by surgery (unresectable). Trastuzumab emtansine is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug called emtansine. Trastuzumab attaches to HER2 positive cancer cells in a targeted way and delivers emtansine to kill them. Trastuzumab emtansine may work better compared to usual treatment of chemotherapy with docetaxel and trastuzumab in treating patients with salivary gland cancer.
Recruiting1 award Phase 2
More about Daniel Almquist
Clinical Trial Related4 years of experience running clinical trials · Led 84 trials as a Principal Investigator · 68 Active Clinical TrialsTreatments Daniel Almquist has experience with
- Nivolumab
- Pembrolizumab
- Paclitaxel
- Cisplatin
- Carboplatin
- Atezolizumab
Breakdown of trials Daniel Almquist has run
Cancer
Breast Cancer
Lung Cancer
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Daniel Almquist specialize in?
Daniel Almquist focuses on Cancer and Breast Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are p16 positive.
Is Daniel Almquist currently recruiting for clinical trials?
Yes, Daniel Almquist is currently recruiting for 64 clinical trials in Sioux Falls South Dakota. If you're interested in participating, you should apply.
Are there any treatments that Daniel Almquist has studied deeply?
Yes, Daniel Almquist has studied treatments such as Nivolumab, Pembrolizumab, Paclitaxel.
What is the best way to schedule an appointment with Daniel Almquist?
Apply for one of the trials that Daniel Almquist is conducting.
What is the office address of Daniel Almquist?
The office of Daniel Almquist is located at: Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota 57117-5134 United States. This is the address for their practice at the Sanford USD Medical Center - Sioux Falls.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.